Cytokinetics, Incorporated <CYTK.O>: Leerink Partners Raises Target Price to $103 From $100
CYTK•Related News
Karyopharm to report Q2 2026 results, host conference call
KPTI•
BUZZ-AbCellera gains as experimental drug reduces hot flashes in mid-stage trial
ABCL•
Jazz to buy Actio Biosciences for $820 million upfront, up to $500 million more in milestones
JAZZ•
SharpLink Gaming Q2 Net Income USD -394.3 Million
SBET•
Kelly Services Inc <KELYA.O>: Barrington Research raises target price to $20 from $15
KELYA•